The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Mohamedtaki A Tejani, Roger B Cohen, Ranee MehraDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USAAbstract: Recurrent and/or metastatic squamous cell carcinoma of the head and neck (HNSCC) continues to be a source of significant morbidity and mortality worldwide...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/the-contribution-of-cetuximab-in-the-treatment-of-recurrent-andor-meta-a4666 |